Markets Stocks Economy Crypto Earnings Banking Energy
Home› Stocks› Feature
Stocks · Exclusive

Berenberg trims Siemens Healthineers near-term forecasts ahead of spin-off

Berenberg trims Siemens Healthineers near-term forecasts ahead of spin-off
Stocks · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Nov 17, 2026 3 min read

Berenberg, a European investment bank, has nudged its long-term earnings forecasts for Siemens Healthineers after the medical technology company reported a mixed set of fiscal fourth-quarter results. The bank kept its 40-euro price target and a hold rating, but flagged that inflation and a major corporate reshuffle could weigh on the shares into early next year.

What the bank changed

In a note published Tuesday, Berenberg said Siemens Healthineers' latest guidance for fiscal 2026/27 looks more cautious than investors had hoped, with management pointing to lingering inflation pressure and currency swings. As a result, the bank cut its fiscal 2027 adjusted earnings per share estimate by 0.9%. However, it raised its fiscal 2028 and 2029 forecasts by 0.2% and 2.2% respectively, as it looked further out.

That mix of slightly lower near-term numbers and slightly higher later numbers helps explain why Berenberg didn't change either its rating or its price target. The bank's 40-euro target suggests the reshuffle is capping the valuation, even as longer-term earnings potential improves.

The big reshuffle

The near-term narrative for Siemens Healthineers is dominated by structure, not operations. Parent company Siemens AG is planning a spin-off, and Healthineers is carving out its diagnostics unit. Both moves could weigh on sentiment into early next year, according to Berenberg.

Spin-offs and carve-outs can sharpen a company's story over time, but the lead-up often creates an execution discount. Management attention gets split, reporting becomes messier, and it takes longer for investors to compare results year-on-year. Until the timelines firm up and the post-reshuffle financials look easier to analyze, the shares may trade more on uncertainty than on incremental forecast tweaks.

What it means for investors

When an analyst lifts longer-term earnings but keeps the same price target, it often means they're assuming investors won't pay a higher valuation multiple for those future profits. In plain English: more potential earnings, but less confidence in how cleanly the company gets there.

For everyday investors, the key takeaway is that Siemens Healthineers' stock may remain range-bound until the corporate restructuring becomes clearer. The company's fundamentals—its core imaging and diagnostics businesses—are still solid, but the near-term overhangs could keep a lid on the share price.

Berenberg's hold rating reflects that balance: not enough upside to buy, but no reason to sell either. Investors should watch for updates on the spin-off timeline and the diagnostics carve-out, as those could be the catalysts that break the stock out of its current pattern.

This is not the only corporate reshuffle making headlines. BP's board reshuffle and Star Entertainment's management changes show that structural moves can have a big impact on investor sentiment across industries.

For now, Berenberg's tweaks are modest, and the bank's stance is unchanged. The real story is the reshuffle, and until that plays out, expect the shares to trade on headlines rather than fundamentals.

More from this story

Next article · Don't miss

TPG in talks to take BILL Holdings private, Reuters reports

TPG is in talks to take BILL Holdings private, potentially at a premium, after activist investors pushed for changes. The news sent BILL shares up nearly 13% to a 52-week high.

Read the story →
TPG in talks to take BILL Holdings private, Reuters reports